This inventor holds 6 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Genvivo, Inc., Epeius Biotechnologies Corporation. Active years: 2018-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2022
Title: The Innovative Contributions of Rebecca A Reed
Introduction
Rebecca A Reed is a prominent inventor based in Sherman Oaks, California. She has made significant contributions to the field of biotechnology, particularly in the development of gene therapeutic systems. With a total of six patents to her name, her work has had a substantial impact on diagnostic and therapeutic applications.
Latest Patents
Among her latest patents is the invention related to the thymidine kinase gene. This patent provides nucleic acid sequences encoding improved Herpes Simplex Virus Thymidine Kinases, which are crucial for both diagnostic and therapeutic applications. The thymidine kinases can be mutated using conservative mutations, non-conservative mutations, or both. Additionally, she has developed a thymidine kinase diagnostic assay for gene therapy applications, further enhancing the potential for innovative treatments in the medical field.
Career Highlights
Rebecca has worked with notable companies such as Genvivo, Inc. and Epeius Biotechnologies Corporation. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking advancements in biotechnology.
Collaborations
Throughout her career, Rebecca has collaborated with esteemed colleagues, including John P Levy and Joseph McNulty. These partnerships have fostered an environment of innovation and creativity, leading to the development of her impactful patents.
Conclusion
Rebecca A Reed's contributions to biotechnology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in gene therapy and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile